EDSA - Edesa Biotech GAAP EPS of -$0.37 beats by $0.06 August, 12 2022 04:38 PM Edesa Biotech Inc. Edesa Biotech press release ( NASDAQ: EDSA ): Q3 GAAP EPS of -$0.37 beats by $0.06 . At June 30, 2022, Edesa had cash and cash equivalents of $12.81 million and working capital of $9.52 million. For further details see: Edesa Biotech GAAP EPS of -$0.37 beats by $0.06